findmyKOL
Clinical trialNCT01117454CompletedInterventional

Flecainide for Catecholaminergic Polymorphic Ventricular Tachycardia

SponsorVanderbilt University Medical CenterEnrollment14Catecholaminergic Polymorphic Ventricular Tachycardia
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to test whether the addition of oral flecainide to standard therapy will reduce ventricular ectopy on exercise test compared to placebo plus standard therapy in patients with Catecholaminergic Polymorphic Ventricular Tachycardia.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • University of California Los Angeles

    Los Angeles, California, United States

  • Children'S Hospital of Orange County

    Orange, California, United States

  • Nyu Langone Medical Center

    New York, New York, United States

  • Duke University

    Durham, North Carolina, United States

  • East Carolina University

    Greenville, North Carolina, United States

  • Metrohealth Medical Center

    Cleveland, Ohio, United States

  • Nationwide Children'S Hospital

    Columbus, Ohio, United States

  • Vanderbilt University

    Nashville, Tennessee, United States

  • Cook Children'S Hospital

    Fort Worth, Texas, United States

  • University of Utah

    Salt Lake City, Utah, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Beta blockerFlecainide →Placebo
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Dec 2011
Primary completion
31 Dec 2015
Completion
31 Dec 2015
Last update posted
14 Jun 2017
Registered enrollment
14
Registry id
NCT01117454
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.